Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin

Gerardo A. Morfini, Yi Mei You, Sarah L. Pollema, Agnieszka Kaminska, Katherine Liu, Katsuji Yoshioka, Benny Björkblom, Eleanor T. Coffey, Carolina Bagnato, David Han, Chun Fang Huang, Gary Banker, Gustavo Pigino, Scott T. Brady

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

Selected vulnerability of neurons in Huntington's disease suggests that alterations occur in a cellular process that is particularly critical for neuronal function. Supporting this idea, pathogenic Htt (polyQ-Htt) inhibits fast axonal transport (FAT) in various cellular and animal models of Huntington's disease (mouse and squid), but the molecular basis of this effect remains unknown. We found that polyQ-Htt inhibited FAT through a mechanism involving activation of axonal cJun N-terminal kinase (JNK). Accordingly, we observed increased activation of JNK in vivo in cellular and mouse models of Huntington's disease. Additional experiments indicated that the effects of polyQ-Htt on FAT were mediated by neuron-specific JNK3 and not by ubiquitously expressed JNK1, providing a molecular basis for neuron-specific pathology in Huntington's disease. Mass spectrometry identified a residue in the kinesin-1 motor domain that was phosphorylated by JNK3 and this modification reduced kinesin-1 binding to microtubules. These data identify JNK3 as a critical mediator of polyQ-Htt toxicity and provide a molecular basis for polyQ-Htt-induced inhibition of FAT.

Original languageEnglish (US)
Pages (from-to)864-871
Number of pages8
JournalNature Neuroscience
Volume12
Issue number7
DOIs
StatePublished - Jul 2009

Fingerprint

Kinesin
Axonal Transport
Huntington Disease
Neurons
MAP Kinase Kinase 4
Decapodiformes
Microtubules
Mass Spectrometry
Animal Models
polyglutamine
Pathology

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Morfini, G. A., You, Y. M., Pollema, S. L., Kaminska, A., Liu, K., Yoshioka, K., ... Brady, S. T. (2009). Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nature Neuroscience, 12(7), 864-871. https://doi.org/10.1038/nn.2346

Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. / Morfini, Gerardo A.; You, Yi Mei; Pollema, Sarah L.; Kaminska, Agnieszka; Liu, Katherine; Yoshioka, Katsuji; Björkblom, Benny; Coffey, Eleanor T.; Bagnato, Carolina; Han, David; Huang, Chun Fang; Banker, Gary; Pigino, Gustavo; Brady, Scott T.

In: Nature Neuroscience, Vol. 12, No. 7, 07.2009, p. 864-871.

Research output: Contribution to journalArticle

Morfini, GA, You, YM, Pollema, SL, Kaminska, A, Liu, K, Yoshioka, K, Björkblom, B, Coffey, ET, Bagnato, C, Han, D, Huang, CF, Banker, G, Pigino, G & Brady, ST 2009, 'Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin', Nature Neuroscience, vol. 12, no. 7, pp. 864-871. https://doi.org/10.1038/nn.2346
Morfini, Gerardo A. ; You, Yi Mei ; Pollema, Sarah L. ; Kaminska, Agnieszka ; Liu, Katherine ; Yoshioka, Katsuji ; Björkblom, Benny ; Coffey, Eleanor T. ; Bagnato, Carolina ; Han, David ; Huang, Chun Fang ; Banker, Gary ; Pigino, Gustavo ; Brady, Scott T. / Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. In: Nature Neuroscience. 2009 ; Vol. 12, No. 7. pp. 864-871.
@article{3a57514cb8fe459581bc7cec74549029,
title = "Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin",
abstract = "Selected vulnerability of neurons in Huntington's disease suggests that alterations occur in a cellular process that is particularly critical for neuronal function. Supporting this idea, pathogenic Htt (polyQ-Htt) inhibits fast axonal transport (FAT) in various cellular and animal models of Huntington's disease (mouse and squid), but the molecular basis of this effect remains unknown. We found that polyQ-Htt inhibited FAT through a mechanism involving activation of axonal cJun N-terminal kinase (JNK). Accordingly, we observed increased activation of JNK in vivo in cellular and mouse models of Huntington's disease. Additional experiments indicated that the effects of polyQ-Htt on FAT were mediated by neuron-specific JNK3 and not by ubiquitously expressed JNK1, providing a molecular basis for neuron-specific pathology in Huntington's disease. Mass spectrometry identified a residue in the kinesin-1 motor domain that was phosphorylated by JNK3 and this modification reduced kinesin-1 binding to microtubules. These data identify JNK3 as a critical mediator of polyQ-Htt toxicity and provide a molecular basis for polyQ-Htt-induced inhibition of FAT.",
author = "Morfini, {Gerardo A.} and You, {Yi Mei} and Pollema, {Sarah L.} and Agnieszka Kaminska and Katherine Liu and Katsuji Yoshioka and Benny Bj{\"o}rkblom and Coffey, {Eleanor T.} and Carolina Bagnato and David Han and Huang, {Chun Fang} and Gary Banker and Gustavo Pigino and Brady, {Scott T.}",
year = "2009",
month = "7",
doi = "10.1038/nn.2346",
language = "English (US)",
volume = "12",
pages = "864--871",
journal = "Nature Neuroscience",
issn = "1097-6256",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin

AU - Morfini, Gerardo A.

AU - You, Yi Mei

AU - Pollema, Sarah L.

AU - Kaminska, Agnieszka

AU - Liu, Katherine

AU - Yoshioka, Katsuji

AU - Björkblom, Benny

AU - Coffey, Eleanor T.

AU - Bagnato, Carolina

AU - Han, David

AU - Huang, Chun Fang

AU - Banker, Gary

AU - Pigino, Gustavo

AU - Brady, Scott T.

PY - 2009/7

Y1 - 2009/7

N2 - Selected vulnerability of neurons in Huntington's disease suggests that alterations occur in a cellular process that is particularly critical for neuronal function. Supporting this idea, pathogenic Htt (polyQ-Htt) inhibits fast axonal transport (FAT) in various cellular and animal models of Huntington's disease (mouse and squid), but the molecular basis of this effect remains unknown. We found that polyQ-Htt inhibited FAT through a mechanism involving activation of axonal cJun N-terminal kinase (JNK). Accordingly, we observed increased activation of JNK in vivo in cellular and mouse models of Huntington's disease. Additional experiments indicated that the effects of polyQ-Htt on FAT were mediated by neuron-specific JNK3 and not by ubiquitously expressed JNK1, providing a molecular basis for neuron-specific pathology in Huntington's disease. Mass spectrometry identified a residue in the kinesin-1 motor domain that was phosphorylated by JNK3 and this modification reduced kinesin-1 binding to microtubules. These data identify JNK3 as a critical mediator of polyQ-Htt toxicity and provide a molecular basis for polyQ-Htt-induced inhibition of FAT.

AB - Selected vulnerability of neurons in Huntington's disease suggests that alterations occur in a cellular process that is particularly critical for neuronal function. Supporting this idea, pathogenic Htt (polyQ-Htt) inhibits fast axonal transport (FAT) in various cellular and animal models of Huntington's disease (mouse and squid), but the molecular basis of this effect remains unknown. We found that polyQ-Htt inhibited FAT through a mechanism involving activation of axonal cJun N-terminal kinase (JNK). Accordingly, we observed increased activation of JNK in vivo in cellular and mouse models of Huntington's disease. Additional experiments indicated that the effects of polyQ-Htt on FAT were mediated by neuron-specific JNK3 and not by ubiquitously expressed JNK1, providing a molecular basis for neuron-specific pathology in Huntington's disease. Mass spectrometry identified a residue in the kinesin-1 motor domain that was phosphorylated by JNK3 and this modification reduced kinesin-1 binding to microtubules. These data identify JNK3 as a critical mediator of polyQ-Htt toxicity and provide a molecular basis for polyQ-Htt-induced inhibition of FAT.

UR - http://www.scopus.com/inward/record.url?scp=67649826155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649826155&partnerID=8YFLogxK

U2 - 10.1038/nn.2346

DO - 10.1038/nn.2346

M3 - Article

VL - 12

SP - 864

EP - 871

JO - Nature Neuroscience

JF - Nature Neuroscience

SN - 1097-6256

IS - 7

ER -